100
Participants
Start Date
February 6, 2024
Primary Completion Date
March 1, 2024
Study Completion Date
September 30, 2025
Bevacizumab
Bevacizumab dosing is at 15 mg/kg every 3 weeks as an intravenous infusion.
Olaparib
Olaparib dosing is oral at 300 mg twice daily
RECRUITING
Vall d'Hebron Institute of Oncology, Barcelona
Vall d'Hebron Institute of Oncology
OTHER